nodes	percent_of_prediction	percent_of_DWPC	metapath
Icatibant—BDKRB2—respiratory system—chronic obstructive pulmonary disease	0.0546	0.165	CbGeAlD
Icatibant—ANPEP—Metabolism of Angiotensinogen to Angiotensins—ACE—chronic obstructive pulmonary disease	0.0453	0.0951	CbGpPWpGaD
Icatibant—BDKRB2—smooth muscle tissue—chronic obstructive pulmonary disease	0.0439	0.133	CbGeAlD
Icatibant—ANPEP—Cardiac Progenitor Differentiation—TNNT2—chronic obstructive pulmonary disease	0.0412	0.0865	CbGpPWpGaD
Icatibant—BDKRB2—trachea—chronic obstructive pulmonary disease	0.0403	0.122	CbGeAlD
Icatibant—ANPEP—Glutathione metabolism—GCLC—chronic obstructive pulmonary disease	0.0397	0.0833	CbGpPWpGaD
Icatibant—BDKRB2—ACE Inhibitor Pathway—ACE—chronic obstructive pulmonary disease	0.0394	0.0828	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—ELANE—chronic obstructive pulmonary disease	0.0376	0.079	CbGpPWpGaD
Icatibant—ANPEP—respiratory system—chronic obstructive pulmonary disease	0.034	0.103	CbGeAlD
Icatibant—ANPEP—connective tissue—chronic obstructive pulmonary disease	0.03	0.0907	CbGeAlD
Icatibant—BDKRB2—lung—chronic obstructive pulmonary disease	0.029	0.0877	CbGeAlD
Icatibant—ANPEP—bronchus—chronic obstructive pulmonary disease	0.028	0.0848	CbGeAlD
Icatibant—ANPEP—smooth muscle tissue—chronic obstructive pulmonary disease	0.0274	0.0829	CbGeAlD
Icatibant—ANPEP—Glutathione metabolism—GSTM1—chronic obstructive pulmonary disease	0.0256	0.0537	CbGpPWpGaD
Icatibant—ANPEP—trachea—chronic obstructive pulmonary disease	0.0251	0.0761	CbGeAlD
Icatibant—BDKRB2—ACE Inhibitor Pathway—NOS3—chronic obstructive pulmonary disease	0.0183	0.0386	CbGpPWpGaD
Icatibant—ANPEP—lung—chronic obstructive pulmonary disease	0.0181	0.0547	CbGeAlD
Icatibant—BDKRB2—Peptide GPCRs—CXCR2—chronic obstructive pulmonary disease	0.0166	0.0348	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—MPO—chronic obstructive pulmonary disease	0.0145	0.0305	CbGpPWpGaD
Icatibant—BDKRB2—ACE Inhibitor Pathway—TGFB1—chronic obstructive pulmonary disease	0.0121	0.0255	CbGpPWpGaD
Icatibant—ANPEP—Peptide hormone metabolism—ACE—chronic obstructive pulmonary disease	0.0119	0.025	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.00907	0.019	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.00779	0.0164	CbGpPWpGaD
Icatibant—ANPEP—Peptide hormone metabolism—LEP—chronic obstructive pulmonary disease	0.00739	0.0155	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—HDAC2—chronic obstructive pulmonary disease	0.00727	0.0153	CbGpPWpGaD
Icatibant—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00672	0.0347	CcSEcCtD
Icatibant—BDKRB2—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.00657	0.0138	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.0061	0.0128	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.00573	0.012	CbGpPWpGaD
Icatibant—ANPEP—Cardiac Progenitor Differentiation—TGFB1—chronic obstructive pulmonary disease	0.00534	0.0112	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00522	0.011	CbGpPWpGaD
Icatibant—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00505	0.0261	CcSEcCtD
Icatibant—ANPEP—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.00487	0.0102	CbGpPWpGaD
Icatibant—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00457	0.0236	CcSEcCtD
Icatibant—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00453	0.0234	CcSEcCtD
Icatibant—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00448	0.0231	CcSEcCtD
Icatibant—BDKRB2—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.00442	0.00929	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.00437	0.00917	CbGpPWpGaD
Icatibant—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00432	0.0223	CcSEcCtD
Icatibant—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00431	0.0223	CcSEcCtD
Icatibant—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00429	0.0222	CcSEcCtD
Icatibant—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00422	0.0218	CcSEcCtD
Icatibant—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00407	0.021	CcSEcCtD
Icatibant—BDKRB2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00398	0.00836	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.00396	0.00831	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.00387	0.00813	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.00383	0.00804	CbGpPWpGaD
Icatibant—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00361	0.0187	CcSEcCtD
Icatibant—BDKRB2—Direct p53 effectors—SERPINE1—chronic obstructive pulmonary disease	0.00356	0.00748	CbGpPWpGaD
Icatibant—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00348	0.018	CcSEcCtD
Icatibant—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00348	0.018	CcSEcCtD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.00346	0.00727	CbGpPWpGaD
Icatibant—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00341	0.0176	CcSEcCtD
Icatibant—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00341	0.0176	CcSEcCtD
Icatibant—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00341	0.0176	CcSEcCtD
Icatibant—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00337	0.0174	CcSEcCtD
Icatibant—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00334	0.0172	CcSEcCtD
Icatibant—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00328	0.017	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00328	0.00689	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00326	0.00685	CbGpPWpGaD
Icatibant—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00322	0.0166	CcSEcCtD
Icatibant—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00317	0.0164	CcSEcCtD
Icatibant—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00302	0.0156	CcSEcCtD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.00299	0.00628	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00293	0.00615	CbGpPWpGaD
Icatibant—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00288	0.0149	CcSEcCtD
Icatibant—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00288	0.0149	CcSEcCtD
Icatibant—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00286	0.0148	CcSEcCtD
Icatibant—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00285	0.0147	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.00279	0.00586	CbGpPWpGaD
Icatibant—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00275	0.0142	CcSEcCtD
Icatibant—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00275	0.0142	CcSEcCtD
Icatibant—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00272	0.014	CcSEcCtD
Icatibant—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00271	0.014	CcSEcCtD
Icatibant—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00271	0.014	CcSEcCtD
Icatibant—Headache—Tiotropium—chronic obstructive pulmonary disease	0.0027	0.0139	CcSEcCtD
Icatibant—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00269	0.0139	CcSEcCtD
Icatibant—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00259	0.0134	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.00256	0.00538	CbGpPWpGaD
Icatibant—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00256	0.0132	CcSEcCtD
Icatibant—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00256	0.0132	CcSEcCtD
Icatibant—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00256	0.0132	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.00253	0.00532	CbGpPWpGaD
Icatibant—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00251	0.013	CcSEcCtD
Icatibant—BDKRB2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.0025	0.00524	CbGpPWpGaD
Icatibant—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00242	0.0125	CcSEcCtD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.00236	0.00496	CbGpPWpGaD
Icatibant—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.0023	0.0119	CcSEcCtD
Icatibant—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.0023	0.0119	CcSEcCtD
Icatibant—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00225	0.0116	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.00225	0.00472	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.00225	0.00472	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.00223	0.00469	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—EGFR—chronic obstructive pulmonary disease	0.0022	0.00463	CbGpPWpGaD
Icatibant—Rash—Formoterol—chronic obstructive pulmonary disease	0.00219	0.0113	CcSEcCtD
Icatibant—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00219	0.0113	CcSEcCtD
Icatibant—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00219	0.0113	CcSEcCtD
Icatibant—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00219	0.0113	CcSEcCtD
Icatibant—Headache—Formoterol—chronic obstructive pulmonary disease	0.00218	0.0112	CcSEcCtD
Icatibant—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00218	0.0112	CcSEcCtD
Icatibant—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00217	0.0112	CcSEcCtD
Icatibant—Rash—Montelukast—chronic obstructive pulmonary disease	0.00215	0.0111	CcSEcCtD
Icatibant—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00214	0.0111	CcSEcCtD
Icatibant—Headache—Montelukast—chronic obstructive pulmonary disease	0.00213	0.011	CcSEcCtD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	0.0021	0.0044	CbGpPWpGaD
Icatibant—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00207	0.0107	CcSEcCtD
Icatibant—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00207	0.0107	CcSEcCtD
Icatibant—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00206	0.0107	CcSEcCtD
Icatibant—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00206	0.0107	CcSEcCtD
Icatibant—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00206	0.0106	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.00204	0.00429	CbGpPWpGaD
Icatibant—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00202	0.0104	CcSEcCtD
Icatibant—ANPEP—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.00202	0.00424	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.00199	0.00418	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.00197	0.00415	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.00195	0.0041	CbGpPWpGaD
Icatibant—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00195	0.0101	CcSEcCtD
Icatibant—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00188	0.00972	CcSEcCtD
Icatibant—BDKRB2—Direct p53 effectors—TP53—chronic obstructive pulmonary disease	0.00185	0.00388	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.00158	0.00333	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.00156	0.00328	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.0015	0.00314	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.00144	0.00303	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.00141	0.00296	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.0014	0.00293	CbGpPWpGaD
Icatibant—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00139	0.00716	CcSEcCtD
Icatibant—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00137	0.00707	CcSEcCtD
Icatibant—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.00134	0.00693	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.00128	0.00269	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.00126	0.00265	CbGpPWpGaD
Icatibant—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00124	0.00643	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.00121	0.00253	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.00121	0.00253	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.0012	0.00252	CbGpPWpGaD
Icatibant—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00119	0.00613	CcSEcCtD
Icatibant—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00119	0.00613	CcSEcCtD
Icatibant—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00118	0.00609	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.00114	0.0024	CbGpPWpGaD
Icatibant—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00112	0.00578	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.0011	0.00232	CbGpPWpGaD
Icatibant—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00108	0.00559	CcSEcCtD
Icatibant—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00521	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.001	0.0021	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	0.000927	0.00195	CbGpPWpGaD
Icatibant—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000905	0.00467	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000882	0.00185	CbGpPWpGaD
Icatibant—Rash—Prednisone—chronic obstructive pulmonary disease	0.000863	0.00446	CcSEcCtD
Icatibant—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000862	0.00445	CcSEcCtD
Icatibant—Headache—Prednisone—chronic obstructive pulmonary disease	0.000857	0.00443	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.00082	0.00172	CbGpPWpGaD
Icatibant—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000813	0.0042	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000757	0.00159	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000681	0.00143	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000676	0.00142	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000619	0.0013	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000615	0.00129	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000592	0.00124	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.00055	0.00116	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000452	0.00095	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000432	0.000907	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000412	0.000866	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000365	0.000768	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000348	0.00073	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000331	0.000694	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000297	0.000624	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.000272	0.000572	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	0.000267	0.000561	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	0.000224	0.000471	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	0.000205	0.000431	CbGpPWpGaD
